BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10794431)

  • 1. Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: molecular and cellular characterization.
    Mella P; Imberti L; Brugnoni D; Pirovano S; Candotti F; Mazzolari E; Bettinardi A; Fiorini M; De Mattia D; Martire B; Plebani A; Notarangelo LD; Giliani S
    Clin Immunol; 2000 Apr; 95(1 Pt 1):39-50. PubMed ID: 10794431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with T⁺/low NK⁺ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency.
    Fuchs S; Rensing-Ehl A; Erlacher M; Vraetz T; Hartjes L; Janda A; Rizzi M; Lorenz MR; Gilmour K; de Saint-Basile G; Roifman CM; Cheuk S; Gennery A; Thrasher AJ; Fuchs I; Schwarz K; Speckmann C; Ehl S
    Eur J Immunol; 2014 Oct; 44(10):3129-40. PubMed ID: 25042067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical X-linked SCID phenotype associated with growth hormone hyporesponsiveness.
    Ursini MV; Gaetaniello L; Ambrosio R; Matrecano E; Apicella AJ; Salerno MC; Pignata C
    Clin Exp Immunol; 2002 Sep; 129(3):502-9. PubMed ID: 12197892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
    Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
    Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
    Russell SM; Tayebi N; Nakajima H; Riedy MC; Roberts JL; Aman MJ; Migone TS; Noguchi M; Markert ML; Buckley RH; O'Shea JJ; Leonard WJ
    Science; 1995 Nov; 270(5237):797-800. PubMed ID: 7481768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model.
    Notarangelo LD; Giliani S; Mazza C; Mella P; Savoldi G; Rodriguez-Pérez C; Mazzolari E; Fiorini M; Duse M; Plebani A; Ugazio AG; Vihinen M; Candotti F; Schumacher RF
    Immunol Rev; 2000 Dec; 178():39-48. PubMed ID: 11213805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.
    Puck JM; Deschênes SM; Porter JC; Dutra AS; Brown CJ; Willard HF; Henthorn PS
    Hum Mol Genet; 1993 Aug; 2(8):1099-104. PubMed ID: 8401490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient.
    Morelon E; Dautry-Varsat A; Le Deist F; Hacein-Bay S; Fischer A; de Saint Basile G
    Blood; 1996 Sep; 88(5):1708-17. PubMed ID: 8781427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.
    Stephan V; Wahn V; Le Deist F; Dirksen U; Broker B; Müller-Fleckenstein I; Horneff G; Schroten H; Fischer A; de Saint Basile G
    N Engl J Med; 1996 Nov; 335(21):1563-7. PubMed ID: 8900089
    [No Abstract]   [Full Text] [Related]  

  • 10. Signaling via the IL-2 and IL-7 receptors from the membrane to the nucleus.
    Leonard WJ; Imada K; Nakajima H; Puel A; Soldaini E; John S
    Cold Spring Harb Symp Quant Biol; 1999; 64():417-24. PubMed ID: 11232316
    [No Abstract]   [Full Text] [Related]  

  • 11. An interleukin-2 receptor gamma chain mutation with normal thymus morphology.
    Sharfe N; Shahar M; Roifman CM
    J Clin Invest; 1997 Dec; 100(12):3036-43. PubMed ID: 9399950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutant gammac chain from a patient with typical phenotype of X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action.
    Kumaki S; Ochs HD; Kuropatwinski KK; Konno T; Timour MS; Cosman D; Baumann H
    Clin Exp Immunol; 1999 Feb; 115(2):356-61. PubMed ID: 9933465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase.
    Brugnoni D; Notarangelo LD; Sottini A; Airò P; Pennacchio M; Mazzolari E; Signorini S; Candotti F; Villa A; Mella P; Vezzoni P; Cattaneo R; Ugazio AG; Imberti L
    Blood; 1998 Feb; 91(3):949-55. PubMed ID: 9446656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and immunodeficiency diseases.
    Leonard WJ
    Nat Rev Immunol; 2001 Dec; 1(3):200-8. PubMed ID: 11905829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency.
    Puck JM; Pepper AE; Bédard PM; Laframboise R
    J Clin Invest; 1995 Feb; 95(2):895-9. PubMed ID: 7860773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked SCID and other defects of cytokine pathways.
    Uribe L; Weinberg KI
    Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model.
    Notarangelo LD; Giliani S; Mella P; Schumacher RF; Mazza C; Savoldi G; Rodriguez-Pérez C; Badolato R; Mazzolari E; Porta F; Candotti F; Ugazio AG
    Immunobiology; 2000 Aug; 202(2):106-19. PubMed ID: 10993286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the gene for the IL-7 receptor result in T(-)B(+)NK(+) severe combined immunodeficiency disease.
    Puel A; Leonard WJ
    Curr Opin Immunol; 2000 Aug; 12(4):468-73. PubMed ID: 10899029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling.
    Leonard WJ
    Annu Rev Med; 1996; 47():229-39. PubMed ID: 8712778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype.
    Ginn SL; Smyth C; Wong M; Bennetts B; Rowe PB; Alexander IE
    Hum Mutat; 2004 May; 23(5):522-3. PubMed ID: 15108287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.